Evidence map›Paper›PMID 33415010›Full record

ArticleAmerican journal of cancer research2020

Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.

Lindsay West, Yajie Yin, Stuart R Pierce, Ziwei Fang, Yali Fan, Wenchuan Sun, Katherine Tucker, Allison Staley, Chunxiao Zhou, Victoria Bae-Jump

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06887673 (Exploring the Impact of Montelukast, SPM, and/or Almond/Almond Oil Supplementation on Lipid Mediator Biosynthesis in Colorectal, Sarcomas, Brain Tumors, Endometrial, and Ovarian Cancer), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06887673 early_phase1not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Exploring the Impact of Montelukast, SPM, and/or Almond/Almond Oil Supplementation on Lipid Mediator Biosynthesis in Colorectal, Sarcomas, Brain Tumors, Endometrial, and Ovarian Cancer: A Pilot Study

TypeinterventionalSponsorUniversity of South FloridaRan2025 to 2026Enrolled56ConditionsColorectal Cancer, Sarcoma, Brain Tumors, Endometrial CancerArmsNo Interventions, Sports Pro Resolve 4 g, Double Wood SPM 4 g, 20 California Sweet Almonds, Montelukast 10 Mg Oral Tablet
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Lindsay WestDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Yajie YinDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Stuart R PierceDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Ziwei FangDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Yali FanDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Wenchuan SunDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Katherine TuckerDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Allison StaleyDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Chunxiao ZhouDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Victoria Bae-JumpDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · US

Funding

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial CancerR37CA226969 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BAE-JUMP, VICTORIA LIN · 2018 to 2024
$2.5M
NCI NIH HHS R37 CA226969
6 · The paper itself

Abstract

Omega-3 polyunsaturated fatty acids (PUFAs), such as those found in fish oil, are thought to have anti-tumorigenic effects and may help to treat and prevent cancer, including ovarian cancer. Thus, we aimed to evaluate the potential of docosahexaenoic acid (DHA), an omega-3 PUFA, as a therapeutic agent in ovarian cancer cell lines and a transgenic mouse model of ovarian cancer. DHA significantly inhibited cellular proliferation, induced cell cycle arrest and caused apoptosis in Hey and IGROV-1 cells. Pre-treatment with the anti-oxidant, N-acetylcysteine (NAC), reversed DHA-induced caspase 3 activity and prevented DHA-reduced cell proliferation. DHA also induced cellular reactive oxygen species (ROS) and inhibited adhesion and invasion in IGROV-1 and Hey cells. Furthermore, treatment with DHA demonstrated anti-tumorigenic and anti-invasive activity in a K18-gT

Indexed as

apoptosisDocosahexaenoic acidinvasionovarian cancerproliferation

Identifiers

PMID33415010
PMCPMC7783742
OpenAlexW3118727282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.